These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17185207)

  • 21. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD; Hlatky MA; Owens DK
    N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
    Brown GC; Brown MM; Lieske HB; Lieske PA; Brown KS; Lane SS
    Ophthalmology; 2011 Sep; 118(9):1834-43. PubMed ID: 21723614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of active case-finding strategies in tuberculosis control in Kampala, Uganda.
    Mupere E; Schiltz NK; Mulogo E; Katamba A; Nabbuye-Sekandi J; Singer ME
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):207-13. PubMed ID: 23317956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.
    Zeliadt SB; Etzioni RD; Penson DF; Thompson IM; Ramsey SD
    Am J Med; 2005 Aug; 118(8):850-7. PubMed ID: 16084177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial.
    Bakhai A; Stone GW; Grines CL; Murphy SA; Githiora L; Berezin RH; Cox DA; Stuckey T; Griffin JJ; Tcheng JE; Cohen DJ;
    Circulation; 2003 Dec; 108(23):2857-63. PubMed ID: 14610016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of interventions for depressed Latinos.
    Schoenbaum M; Miranda J; Sherbourne C; Duan N; Wells K
    J Ment Health Policy Econ; 2004 Jun; 7(2):69-76. PubMed ID: 15208467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis.
    Gourevitch MN; Alcabes P; Wasserman WC; Arno PS
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):531-40. PubMed ID: 9661818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer.
    Liberato NL; Marchetti M; Barosi G
    J Clin Oncol; 2007 Feb; 25(6):625-33. PubMed ID: 17308267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.
    Feldman AM; de Lissovoy G; Bristow MR; Saxon LA; De Marco T; Kass DA; Boehmer J; Singh S; Whellan DJ; Carson P; Boscoe A; Baker TM; Gunderman MR
    J Am Coll Cardiol; 2005 Dec; 46(12):2311-21. PubMed ID: 16360064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB.
    Aspler A; Long R; Trajman A; Dion MJ; Khan K; Schwartzman K; Menzies D
    Thorax; 2010 Jul; 65(7):582-7. PubMed ID: 20627913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.
    Henderson C; Knapp M; Fernández JL; Beecham J; Hirani SP; Cartwright M; Rixon L; Beynon M; Rogers A; Bower P; Doll H; Fitzpatrick R; Steventon A; Bardsley M; Hendy J; Newman SP;
    BMJ; 2013 Mar; 346():f1035. PubMed ID: 23520339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling.
    Pinget C; Martin E; Wasserfallen JB; Humair JP; Cornuz J
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):451-5. PubMed ID: 17568248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study.
    Patel AR; Campbell JR; Sadatsafavi M; Marra F; Johnston JC; Smillie K; Lester RT
    BMJ Open; 2017 Sep; 7(9):e015108. PubMed ID: 28918407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico.
    Burgos JL; Kahn JG; Strathdee SA; Valencia-Mendoza A; Bautista-Arredondo S; Laniado-Laborin R; Castañeda R; Deiss R; Garfein RS
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):962-8. PubMed ID: 19723375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outlook for tuberculosis elimination in California: An individual-based stochastic model.
    Goodell AJ; Shete PB; Vreman R; McCabe D; Porco TC; Barry PM; Flood J; Marks SM; Hill A; Cattamanchi A; Kahn JG
    PLoS One; 2019; 14(4):e0214532. PubMed ID: 30964878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost for tuberculosis care in developed countries: which data for an economic evaluation?
    Trieste L; Turchetti G
    J Rheumatol Suppl; 2014 May; 91():83-5. PubMed ID: 24789005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users.
    Batki SL; Gruber VA; Bradley JM; Bradley M; Delucchi K
    Drug Alcohol Depend; 2002 May; 66(3):283-93. PubMed ID: 12062463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latent variable assessment of outcomes in a nurse-managed intervention to increase latent tuberculosis treatment completion in homeless adults.
    Nyamathi A; Stein JA; Schumann A; Tyler D
    Health Psychol; 2007 Jan; 26(1):68-76. PubMed ID: 17209699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs.
    Sindelar JL; Olmstead TA; Peirce JM
    Addiction; 2007 Sep; 102(9):1463-71. PubMed ID: 17645428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.